Composite MACE outcomes no different among PsA pts treated w/ biologics and DMARDs. Abs 1833 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/TxyE4Uqttq https://t.co/Eykxwmcc44
Links:
Risk of Major Adverse Cardiovascular Events (MACE) with Biologic and Targeted S…
http://ow.ly/pNvj50Gu9Ch
09-11-2021